Efficacy and safety of bromfenac 0.09% and sodium hyaluronate 0.4% combination therapy, versus placebo in patients with pterygium I–III for clinical signs on ocular inflammation

Efficacy and safety of bromfenac 0.09% and sodium hyaluronate 0.4% combination therapy, versus placebo in patients with pterygium I–III for clinical signs on ocular inflammation

Eduardo Chávez-Mondragón,1 Claudia Palacio,2 Abraham Soto-Gómez,3 Miguel Villanueva-Nájera,4 Guillermo De Wit-Carter,5 Ruben Suárez-Velasco,6 Leopoldo Baiza-Duran,7 Oscar Olvera-Montaño,7 Patricia Muñoz-Villegas71Fundaci&am...

Full description

Bibliographic Details
Main Authors: Chávez-Mondragón E, Palacio C, Soto-Gómez A, Villanueva-Nájera M, De Wit-Carter G, Suárez-Velasco R, Baiza-Duran L, Olvera-Montaño O, Muñoz-Villegas P
Format: Article
Language:English
Published: Dove Medical Press 2019-05-01
Series:Clinical Ophthalmology
Subjects:
Nonsteroidal anti-inflammatory drug
Ocular Surface Disease Index
conjunctival hyperemia
ocular lubricant.
Online Access:https://www.dovepress.com/efficacy-and-safety-of-bromfenac-009-and-sodium-hyaluronate-04-combina-peer-reviewed-article-OPTH

Internet

https://www.dovepress.com/efficacy-and-safety-of-bromfenac-009-and-sodium-hyaluronate-04-combina-peer-reviewed-article-OPTH

Similar Items